[Clinical development of drugs related to natriuretic peptides].
Furuya
Mayumi
M
Daiichi Suntory Biomedical Research Co. Ltd.
D000130:Achondroplasia / Q000188:drug therapy; D000818:Animals; D002318:Cardiovascular Diseases / Q000188:drug therapy; D002320:Cardiovascular Physiological Phenomena; D002986:Clinical Trials as Topic; D004304:Dosage Forms; D015195:Drug Design; D006162:Guanylate Cyclase / Q000502:physiology; D006801:Humans; D008024:Ligands; D045265:Natriuretic Peptides / Q000494:pharmacology / Q000502:physiology* / Q000627:therapeutic use*; D015260:Neprilysin / Q000037:antagonists & inhibitors / Q000502:physiology; D011480:Protease Inhibitors / Q000627:therapeutic use; D017461:Receptors, Atrial Natriuretic Factor / Q000819:agonists / Q000502:physiology; D000074261:Receptors, Enterotoxin; D050705:Receptors, Guanylate Cyclase-Coupled; D018000:Receptors, Peptide / Q000502:physiology; D014882:Water-Electrolyte Balance; D000099242:Atrial Natriuretic Factor Receptor B
D004304:Dosage Forms; D006162:Guanylate Cyclase; D008024:Ligands; D045265:Natriuretic Peptides; D015260:Neprilysin; D011480:Protease Inhibitors; D017461:Receptors, Atrial Natriuretic Factor; D000074261:Receptors, Enterotoxin; D050705:Receptors, Guanylate Cyclase-Coupled; D018000:Receptors, Peptide; D000099242:Atrial Natriuretic Factor Receptor B; C091715:atrial natriuretic factor receptor A